About David Narrow
David Narrow is a chief executive officer and director at Sonavex.
David Narrow first appears on SEC filings in 2015.
Experience
This experience comes from David Narrow's profile and from SEC filings. For roles taken from filings, the years are when the filings name David Narrow in the role, so the role may have started earlier or lasted longer.
MI
MedTech Innovator Current
Showcase Company
2020 – Present
TU
The Johns Hopkins University Current
External Advisory Board Member, Center for Bioengineering Innovation & Design
2017 – Present
Sonavex, Inc. Current
CEO (2015 – Present)
Director
2015 – Present · Baltimore, MD
Automated ultrasound devices help dialysis care teams assess blood vessels.
MI
MonoMano, Inc. Current
Co-founder & CEO
2012 – Present
HA
Health Advances
Analyst
2013 – 2014
JU
Johns Hopkins University
Graduate Student: Center for Bioengineering Innovation and Design
2010 – 2013
JB
Julius Wolff Institut, Charité - Universitätsmedizin Berlin
DAAD RISE Research Fellow
2011
UC
University of Rochester Medical Center
Research Assistant (Department of Otolaryngology)
2010
SC
St. Joseph Medical Center
Research Intern (Orthopaedic Spinal Research Lab)
2007 – 2008
Key Colleagues at Startups
The people David Narrow works with at each company, as listed on that company's latest Form D.
Sonavex, Inc. · Form D, Jul 28, 2026
Alex Yevzlin
Chief Medical Officer
RH
Robert Hallenbeck
Director
Devin O'Brien-Coon
Chairman
William Niland
Director
MJ
Michael Hennessy, Jr.
Director
Evan Pritchard
Director